MELISSA FRENCH: Open Payments
NPI 1760831994 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 13 payments from 10 companies in 2025. Trend: 2023 $193 · 2024 $122 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 3 | $89 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Edwards Lifesciences Corporation | 1 | $35 |
| Exelixis Inc. | 1 | $28 |
| BridgeBio Pharma, Inc. | 1 | $26 |
| CVRx, Inc. | 1 | $24 |
| Kestra Medical Technology Services, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $19 |
| Amgen Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: ONPATTRO, LEQVIO, ELIQUIS, CABOMETYX, Attruby, Barostim Neo System, Assure WCD, REPATHA.
Industry payments across FL — which companies pay providers there.
